3D Bioprinting Market Report
3D Bioprinting Market is segmented By Technology (Inkjet-based, Magnetic Levitation, Syringe-based, Laser-based, Others), By Component (3D Bioprinters, Biomaterials, Scaffolds), By Application (Medical [Tissue and organ generation, Medical pills, Prosthetics, and implants], Dental, Biosensors, Consumer/Personal Product Testing, Bioinks, Food & Animal Products) and Region - COVID-19 Impact Analysis and Forecast to 2026. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global 3D bioprinting market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
3D Bioprinting Market is segmented By Technology (Inkjet-based, Magnetic Levitation, Syringe-based, Laser-based, Others), By Component (3D Bioprinters, Biomaterials, Scaffolds), By Application (Medical [Tissue and organ generation, Medical pills, Prosthetics, and implants], Dental, Biosensors, Consumer/Personal Product Testing, Bioinks, Food & Animal Products) and Region - ...
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The 3D Bioprinting Market is estimated to grow from USD 1.4 billion in 2020 to USD 3.8 billion by 2026 at a healthy CAGR of 18.2% during the forecast period.
3D bioprinting is a form of additive manufacturing that utilizes 3D printing to fabricate biomedical parts which maximally imitate natural tissue characteristics. This printing utilizes the layer-by-layer method to deposit materials called bioinks, to create tissue-like structures which are later used in tissue and medical engineering fields.
Key players operating in the 3D bioprinting market are-
The limited number of organ donors and an increasingly senior population with chronic respiratory diseases are expected to boost the demand for 3D bioprinting.
Some other factors augmenting the market growth are-
Moreover, a surge in public and private funding to support bioprinting research activities further offer immense growth opportunities to the industry players in the coming years.
Based on technology, the 3D bioprinting market is classified into inkjet-based, magnetic levitation, syringe-based, laser-based, and others. The inkjet-based segment held a significant market share in 2020 and is estimated to register a healthy CAGR during the forecast timeline. This is mainly ascribed to its ability of printing complex living organs or tissues on the culture substrates with the help of biomaterials, such as bio-inks, which bolsters the segment growth.
By region, the North American market accounted for a significant share in 2020 and is expected to grow at a substantial CAGR in the following years. This is mainly attributed to a growing demand for 3D bioprinting as this technology has been reconnoitered for drug testing and organ transplantation. Also, the highly advanced health care industry, presence of major market players, robust research & development infrastructure, growing awareness of 3D Bioprinting, and technological developments in the region, further proliferate the regional market growth.
The COVID-19 outbreak has positively influenced the 3D bioprinting industry. The pandemic has turned the lives of people worldwide, with the number of cases increasing rapidly. The pandemic resulted in increasing coronavirus patients across the globe, putting a strain on the healthcare sector with limited hospital staff. Hence, as a reaction to the increasing cases of coronavirus, several 3D bioprinting companies are responding to the crises by offering their respective skills to ease the burden on the supply chain and governments. Due to the ever-increasing COVID-19 cases, the demand for 3D bioprinters is surging and the market for 3D bioprinting.
Here is the list of the group of customers that the 3D Bioprinting market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at email@example.com.
The 3D bioprinting market size is expected to reach USD 3.8 billion in the coming years.
The 3D bioprinting market is expected to grow at an impressive CAGR of 18.2% during the foreseeable future.
3D Systems Corporation (US), Aspect Biosystems Ltd (Canada), GeSIM GmbH (Germany), Allevi Inc. (US), Cyfuse Biomedical KK (Japan), Envision TEC GmbH (Germany), Organovo Holdings Inc. (US), RegenHU SA (Switzerland), Stratasys Ltd (US), REGEMAT 3D (Spain) are the key players in the 3D bioprinting market.
North America is expected to grow at a substantial CAGR in the 3D bioprinting market in the coming years.
The inkjet-based segment is expected to register a healthy CAGR in the 3D bioprinting market during the forecast period.
3D bioprinting vendors, 3D bioprinting retailers, Medical device companies, Hospitals are the target audience in the 3D bioprinting market.